QCast: Data-Driven Dialogue in Drug Development podcast

Episode 64: Tipping Point Analysis in Clinical Trials

0:00
10:13
Rewind 15 seconds
Fast Forward 15 seconds

Tipping point analysis helps trial teams understand how strongly a study conclusion depends on assumptions about missing data. In this QCast episode, co-hosts Jullia and Tom discuss how the method relates to MAR and MNAR, how delta adjustments can identify a tipping point, and why the numerical result still needs clinical interpretation.

Key Takeaways

  • Tipping point analysis tests how far assumptions about missing outcomes must change before a predefined trial conclusion changes.
  • The tipping point needs to be interpreted in clinical context, including the endpoint scale, reasons for missingness, and number of participants affected.
  • Continuous, binary, and time-to-event endpoints require different approaches, and prespecification helps keep the analysis aligned with the intended clinical question.


๐Ÿ”— Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
๐Ÿ“ Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
๐Ÿ”” Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.

About Quanticate

Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:

  • Clinical Data Capture & Management
  • Biostatistics & Statistical Consultancy
  • Statistical Programming & PK/PD Analysis
  • Medical Writing & Pharmacovigilance
  • Regulatory & Submission Support
  • AI & Automation
  • Post-Marketing Safety & Real-World Data

Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

More episodes from "QCast: Data-Driven Dialogue in Drug Development"